Abstract
Dear Editor,
We would like to comment on “Benefit-Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study.” 1 By assembling the opinions of endocrinologists and diabetologists, the study aimed to explore the advantages and disadvantages of using ChatGPT in the management of diabetes and metabolic disorders. Twenty-five professionals in the field were interviewed as part of the convenience sample for the qualitative research approach. Key themes from the interviews were found through thematic analysis, yielding 19 codes pertaining to benefits and 7 themes pertaining to hazards. According to the study, using ChatGPT and AI to manage these illnesses may enhance patient outcomes by enhancing diagnosis accuracy, providing more individualized care, and making effective use of available resources.
The use of a convenience sample, which might not fairly represent the larger community of endocrinologists and diabetologists, is one potential issue with the study’s methodology. This could introduce biases into the data and reduce how broadly the conclusions can be applied. Furthermore, the study omitted details on the participants’ backgrounds or traits, which would have been crucial to comprehending the viewpoints expressed in the interviews. More information on the participants and a more representative and diverse sample would be useful in future study.
The study’s lack of discussion on the restrictions on employing ChatGPT and AI to manage metabolic diseases and diabetes is one of its weak points. The study did not examine the difficulties and constraints of using AI to make complex medical decisions, even if it did identify potential advantages and hazards. Future studies could examine the limitations, potential biases, and ethical issues surrounding the use of AI in healthcare settings. Furthermore, further research is required to determine the best ways to incorporate AI technologies into clinical practice while maintaining patient-centered care.
Regarding future directions, it would be beneficial to carry out follow-up research to monitor the real application and results of ChatGPT in the treatment of metabolic diseases and diabetes. Studies with a longitudinal design may evaluate the long-term effects on patient outcomes, physician satisfaction, and the use of healthcare resources. Further investigation could also look into solutions to deal with the risks and difficulties that have been discovered, such as the requirement for explainable AI and worries about data security. Research, medical practitioners, and AI developers working together may help enhance the application of AI to better manage these illnesses. Finally, human user behavior code is needed because ChatGPT output is entirely dependent on human user commands. 2
Footnotes
Acknowledgements
None.